Article History
Received: 23 August 2023
Accepted: 20 November 2023
First Online: 8 January 2024
Declarations
:
: RB has received grants and consultancy fees from La Jolla Pharmaceuticals, Paion AG, and Viatris. AZ has received consulting fees from Astute-Biomerieux, Baxter, Bayer, Novartis, Guard Therapeutics, AM Pharma, Paion, Fresenius, research funding from Astute-Biomerieux, Fresenius, Baxter, and speaker fees from Astute-Biomerieux, Fresenius, Baxter, and Paion. GL has received speaker fees from Medis, Paion, and Viatris and consultancy fees from Paion and Viatris.
Free to read: This content has been made available to all.